ABAX Abaxis, Inc. (delisted)

UNION CITY, Calif., Sept. 19 /PRNewswire-FirstCall/ -- ABAXIS, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at the 2006 UBS Global Life Sciences Conference on Tuesday, September 26, 2006 at 8:30 a.m. Eastern Time at Grand Hyatt Hotel in New York City, New York. Interested parties can access the webcast of the presentation at http://www.ibb.ubs.com/. Click on the conferences icon, then click on the Global Life Sciences Conference event and follow the link for the webcast. About Abaxis Abaxis develops, manufactures, and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 6.9 kilogram (15 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 14 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. Contact: Clint Severson Lytham Partners, LLC Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc. 602-889-9700 510-675-6500 DATASOURCE: Abaxis, Inc. CONTACT: Clint Severson, Chief Executive Officer of ABAXIS, Inc., +1-510-675-6500; or Joe Dorame, Joe Diaz & Robert Blum, all of Lytham Partners, LLC, +1-602-889-9700, for ABAXIS, Inc.

Copyright